Liminatus Pharma, Inc. Warrants (LIMNW) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 2.78M | 500.57K | 1.2M | 1.78M | 0 | 812.66K | 394.19K | 409.16K | 1.51M | 210.88K | 356.48K |
| Cash & Short-Term Investments | 1.91M | 337.65K | 724.5K | 1.34M | 0 | 804.54K | 358.18K | 339.2K | 1.47M | 434K | 337.72K |
| Cash Only | 1.91M | 337.65K | 724.5K | 1.34M | 0 | 804.54K | 358.18K | 339.2K | 1.47M | 434K | 337.72K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 6.46K | 15.76K | 24.46K | 35.36K | 945K | 1.26K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 870.87K | 162.92K | 478.87K | 444.09K | 0 | 1.66K | 20.25K | 45.5K | 5K | -1.17M | 17.5K |
| Total Non-Current Assets | 11.7K | 12.22K | 139.04K | 126.47K | 0 | 2.02M | 2.67M | 3.13M | 3.12M | 4.29M | 4.2M |
| Property, Plant & Equipment | 11.7K | 12.22K | 12.76K | 198 | 0 | 0 | 0 | 0 | 1K | 1K | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 2.02M | 2.67M | 3.13M | 3.12M | 4.29M | 4.2M |
| Other Non-Current Assets | 0 | 0 | 126.28K | 126.28K | 0 | 0 | 0 | 0 | -1K | -1K | 0 |
| Total Assets | 2.79M | 512.79K | 1.34M | 1.91M | 0 | 2.83M | 3.07M | 3.54M | 4.63M | 4.5M | 4.56M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | - | -81.87% | -56.25% | -46.01% | -100% | -37.17% | -32.69% | - | - | - | - |
| Total Current Liabilities | 2.89M | 10.3M | 2.86M | 10.52M | 1.06K | 8.68M | 7.54M | 6.47M | 6.95M | 5.16M | 4.6M |
| Accounts Payable | 529.78K | 582.23K | 559.17K | 431.87K | 0 | 0 | 0 | 0 | 939K | 933K | 0 |
| Days Payables Outstanding | 96.6K | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 1.44M | 1.44M | 1.44M | 1.44M | 0 | 5.12M | 4.57M | 3.77M | 4.24M | 16.05M | 1.78M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 862.92K | 8.64M | 0 | 3.56M | 2.94M | 2.68M | 18.91K | -12.88M | 2.45M |
| Current Ratio | 0.96x | 0.05x | 0.42x | 0.17x | - | 0.09x | 0.05x | 0.06x | 0.22x | 0.04x | 0.08x |
| Quick Ratio | 0.96x | 0.05x | 0.42x | 0.17x | - | 0.09x | 0.05x | 0.06x | 0.22x | 0.04x | 0.08x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 33.42K | 29.24K | 123.58K | 200.45K | 0 | 10.02M | 9.79M | 10.14M | 10.22M | 10.04M | 10.16M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 33.42K | 29.24K | 123.58K | 200.45K | 0 | 10.02M | 9.79M | 10.14M | 10.22M | 10.04M | 10.16M |
| Total Liabilities | 2.92M | 10.33M | 2.99M | 10.72M | 1.06K | 18.7M | 17.32M | 16.61M | 17.16M | 15.19M | 14.76M |
| Total Debt | 1.44M | 1.44M | 1.44M | 1.44M | 0 | 5.12M | 4.57M | 3.77M | 4.24M | 16.05M | 1.78M |
| Net Debt | -465.17K | 1.1M | 718K | 104.28K | 0 | 4.32M | 4.21M | 3.43M | 2.77M | 15.62M | 1.45M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -59.29x | -427.79x | -94.70x | 2.82x | 1.00x | -5.33x | -6.88x | -6.86x | -26.84x | -21.76x | - |
| Total Equity | -132.6K | -9.81M | -1.65M | -8.81M | -1.06K | -15.87M | -14.25M | -13.07M | -12.53M | -10.69M | -10.21M |
| Equity Growth % | -12409.06% | 38.16% | 88.45% | 32.61% | 99.99% | -48.42% | -39.67% | - | - | - | - |
| Book Value per Share | -0.01 | -0.41 | -0.06 | -0.38 | -0.00 | -2.24 | -1.99 | -1.82 | -1.65 | -1.46 | -1.26 |
| Total Shareholders' Equity | -132.6K | -9.81M | -1.65M | -8.81M | -1.06K | -15.87M | -14.25M | -13.07M | -12.53M | -10.69M | -10.21M |
| Common Stock | 4.82K | 2.71K | 2.71K | 2.6K | 0 | 1.76M | 2.45M | 2.92M | 2.87M | 4.05M | 3.99M |
| Retained Earnings | -40M | -38.87M | -30.7M | -28.88M | -1.06K | -17.52M | -16.64M | -15.99M | -15.46M | -14.88M | -14.34M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | -10 | -160.68K | -117.67K | -68.89K | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |